Researchers in the Translational Bioetherapeutics stream are committed to the bench-to-bedside translation of novel therapies for cancer, diabetes, neurological disorders and cardiovascular diseases.
Translational Biotherapeutics
Gene Therapy, Stem Cells and Antibody Therapy
The research into Gene Therapy, Stem Cells and Antibody Therapy is focused on the development of diagnostic, prognostic and treatment protocols for a range of cancers; diabetes gene therapy innovations, including pancreatic trans-differentiation of the liver and the development of liver cells that can secrete insulin; and investigations into environmental triggers for neurodegenerative diseases.
Nano-Biotechnology
The research into nano-biotechnology gives way to developing bio-sensing devices and therapeutics based upon lipid membranes, membrane and ion channel proteins and nanoparticle technologies. This research has exciting real-world application for the treatment of diseases like diabetes, arthritis, control of inflammation and infection.
Notable projects in this area include:
- The UTS Biomarker and Biotherapy Discovery Facility
- Diagnostic testing for diabetic retinopathy
- Gene therapy for type 1 diabetes
- Cancer cell biology and therapeutics
- Environmental factors in neurodegenerative disease